It is the mission of the LFSA as a patient advocacy organization to promote an increased understanding of Li-Fraumeni Syndrome (LFS) and foster scientific advancement that will improve the lives of those living with LFS. We have been aided in this endeavor by the recent formation of a LFS Research Consortium. This group is made up of dedicated physicians and scientists from all over the world with an interest in LFS. It is the hope of the LFSA that through our collaborative efforts we can make great progress in the battle against LFS.
Current areas of active research in the National Cancer Institute’s Li-Fraumeni Syndrome Study include:
- Developing better LFS cancer screening protocols for patients living with LFS
- Determining the influences of environmental factors, diet and metabolism on Li-Fraumeni Syndrome
- Identification of modifying genes and epigenetic events that lead to cancer development in LFS
- Utilizing chemoprevention strategies for patients with LFS
If you have LFS, participation in the study could help researchers in the areas of genetic epidemiology, medical management, and living with LFS. Please reference eligibility criteria for additional information.